Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Locametz 25 ug, Mehrfachdosis-Kit für ein radioaktives Arzneimittel 1
Drug
Locametz, Mehrfachdosis-Kit für ein radioaktives Arzneimittel
PET-Diagnose von PSMA-positivem Prostatakrebs
17.01.9. – tumourdiagnostics
HAM – Human medicine
KIT – Kit for radiopharmaceutical preparation
R – radiopharmaceutic products
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
3/3/2023
3/2/2028
Dosage strength
Locametz 25 ug, Mehrfachdosis-Kit für ein radioaktives Arzneimittel
PET-Diagnose von PSMA-positivem Prostatakrebs
01
Z – approved
Package
No information made available
A/NR – Authorised / not referenced
1 set
001
Z – approved
Declaration
Component
25 µg gozetotidum
natrii acetas trihydricus
natrii chloridum
acidum gentisicum
28.97 mg natrium
natrii chloridum
acidum gentisicum
28.97 mg natrium
Authorisation holder
7601001300477
Novartis Pharma Schweiz AG
6343 Risch (ZG)
6343 Risch (ZG)
Date of revision of the text
6/1/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.